American Association for the Advancement of Science, Science Translational Medicine, 614(13), 2021
DOI: 10.1126/scitranslmed.abg0809
Full text: Unavailable
Alplesib exerts therapeutic effects in a mouse model of lymphatic anomalies and in six patients with lymphatic malformations over 6 months’ treatment.